Atlas Trials

Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake

Clinical trial NCT04957082 · COMPLETED

Trial details

NCT number
NCT04957082
Sponsor
Michigan State University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SARS-CoV2 Infection
Start date
2021-08-04
Primary completion
2022-12-19
Enrollment
666

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.